國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 852311      Online Users : 1523
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Conference Papers/Meeting Abstract [4/6]
    Periodical Articles [9/9]

    Community Statistics


    Item counts issued in 3 years:1(6.67%)
    Items With Fulltext:13(86.67%)

    Download counts of the item
    Download times greater than 0:13(100.00%)
    Download times greater than 100:13(100.00%)
    Total Bitstream Download Counts:8076(0.15%)

    Last Update: 2024-11-28 15:47

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-10 of 15. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2024-04 BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir Antimicrobial Agents and Chemotherapy. 2024 Apr 3;68(4):Article number e0095623
    2021-06-16 Discovery of an orally efficacious MYC inhibitor for liver cancer using a GNMT-based high-throughput screening system and structure-activity relationship analysis Journal of Medicinal Chemistry. 2021 Jun 16;64(13):8992-9009.
    2017-04 Discovery of BPR1K871-a quinazoline based multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation Abstracts of Papers of the American Chemical Society. 2017 Apr;253:Meeting Abstract 482.
    2016-12 Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation Oncotarget. 2016 Dec;7(52):86239-86256.
    2016-11-29 Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
    2015-08 Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180.
    2015-08 Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 182.
    2015-06-29 Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification Scientific Reports. 2015 Jun 29;5:Article number 11702.
    2014-10 Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer Expert Opinion on Investigational Drugs. 2014 Oct;23(10):1333-1348.
    2014-08 Ligand efficiency based approach for efficient virtual screening of compound libraries European Journal of Medicinal Chemistry. 2014 Aug;83:226-235.

    Showing items 1-10 of 15. (2 Page(s) Totally)
    1 2 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback